Literature DB >> 17261380

TCR and Notch synergize in alphabeta versus gammadelta lineage choice.

Annette I Garbe1, Harald von Boehmer.   

Abstract

At two checkpoints, T cell development is controlled by T cell receptor (TCR) signaling, which determines survival and lineage commitment. At the first of these checkpoints, signaling by the pre-TCR, the gammadeltaTCR or the alphabetaTCR has a major but nonexclusive impact on whether cells will become CD4-CD8- gammadelta or CD4+CD8+ alphabeta lineage cells. Pre-TCR signals synergize with moderate Notch signals to generate alphabeta lineage cells. Relatively strong signals by the gammadeltaTCR (or early expressed alphabetaTCR) in the absence of Notch signaling are sufficient to yield gammadelta lineage cells. However, relatively weak signals of the latter two receptors combined with strong Notch signaling result in the formation of alphabeta lineage cells that generate a diverse alphabetaTCR repertoire in pre-TCR-deficient mice. It remains to be determined whether TCR and/or Notch signals instruct or confirm predetermined lineage fate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261380     DOI: 10.1016/j.it.2007.01.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  16 in total

Review 1.  Factors and networks that underpin early hematopoiesis.

Authors:  Elinore M Mercer; Yin C Lin; Cornelis Murre
Journal:  Semin Immunol       Date:  2011-09-18       Impact factor: 11.130

Review 2.  Launching the T-cell-lineage developmental programme.

Authors:  Ellen V Rothenberg; Jonathan E Moore; Mary A Yui
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 3.  Notch signaling in CD4 and CD8 T cell development.

Authors:  Karen Laky; B J Fowlkes
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

Review 4.  Developmental gene networks: a triathlon on the course to T cell identity.

Authors:  Mary A Yui; Ellen V Rothenberg
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

5.  Notch signaling regulates mouse and human Th17 differentiation.

Authors:  Shilpa Keerthivasan; Reem Suleiman; Rebecca Lawlor; Justine Roderick; Tonya Bates; Lisa Minter; Juan Anguita; Ignacio Juncadella; Brian J Nickoloff; I Caroline Le Poole; Lucio Miele; Barbara A Osborne
Journal:  J Immunol       Date:  2011-06-17       Impact factor: 5.422

6.  A critical role for Rictor in T lymphopoiesis.

Authors:  Fei Tang; Qi Wu; Tsuneo Ikenoue; Kun-Liang Guan; Yang Liu; Pan Zheng
Journal:  J Immunol       Date:  2012-07-18       Impact factor: 5.422

7.  The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.

Authors:  Kaat Durinck; Annelynn Wallaert; Inge Van de Walle; Wouter Van Loocke; Pieter-Jan Volders; Suzanne Vanhauwaert; Ellen Geerdens; Yves Benoit; Nadine Van Roy; Bruce Poppe; Jean Soulier; Jan Cools; Pieter Mestdagh; Jo Vandesompele; Pieter Rondou; Pieter Van Vlierberghe; Tom Taghon; Frank Speleman
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

8.  Hypercholesterolemia Increases Colorectal Cancer Incidence by Reducing Production of NKT and γδ T Cells from Hematopoietic Stem Cells.

Authors:  Guodong Tie; Jinglian Yan; Lyne Khair; Julia A Messina; April Deng; Joonsoo Kang; Thomas Fazzio; Louis M Messina
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

9.  ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.

Authors:  Shan Zha; Craig H Bassing; Takaomi Sanda; James W Brush; Harin Patel; Peter H Goff; Michael M Murphy; Suprawee Tepsuporn; Richard A Gatti; A Thomas Look; Frederick W Alt
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

Review 10.  Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination.

Authors:  Ellen V Rothenberg; Deirdre D Scripture-Adams
Journal:  Semin Immunol       Date:  2008-09-03       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.